Efficacy of Rivaroxaban Use in Solid Tumour Malignancy: Experience from a Tertiary Care Cancer Centre.
Azmi Nor Mohd Farez AhmatSharifa Ezat Wan PutehSuhana YusakPublished in: Asian Pacific journal of cancer prevention : APJCP (2021)
The result of this small but important real-world evidence proofs that rivaroxaban is an effective and safe alternative to the standard of care for CAT in Malaysia's cancer population.